Advertisement

Positive inotropic effects of digitoxin- and digoxin-glucuronide in human isolated ventricular heart muscle preparations

  • Hasso Scholz
  • W. Schmitz
Conference paper

Summary

The effect on force of contraction of human isolated ventricular heart muscle preparations was studied with the 16′-glucuronides of digitoxin (dt-gluc) and digoxin (dg-gluc). The parent compounds digitoxin (dt) and digoxin (dg) were studied for comparison and all compounds were also investigated in guinea-pig isolated papillary muscles. All compounds increased myocardial force of contraction in human preparations in a concentration-dependent manner. The positive inotropic effect of dt-gluc and dg-gluc began at 0.1 μmol 1-1 and was maximal at 1 μmol 1-1. The metabolites were slightly less potent but, on the other hand, slightly more effective than the parent compounds dt and dg. The positive inotropic effects of all compounds peaked after about 60 minutes. In contrast, the decline of the positive inotropic effect upon washing was about twice as fast in the case of the hydrophilic metabolites. Similar results were obtained in guinea-pig papillary muscles. It is concluded that the glucuronides of digitoxin and digoxin are biologically active in the human heart. This may be of clinical importance with respect to the positive inotropic action and the plasma level determination of the cardiac glycosides.

Key words

digitoxin-glucuronide digoxin-glucuronide positive inotropic effect human heart 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Belz GG, Heinz N (1977) The influence of polar and non-polar digoxin and digitoxin metabolites on the 86Rb-uptake of human erythrocytes and the contractility of guinea-pig papillary muscles. Arzneim- Forsch. ( Drug Res ) 27: 653–655Google Scholar
  2. 2.
    Lüllmann H, Peters T (1971) The cardioactivity of digitoxin metabolites. Eur J Pharmacol 14: 204–205CrossRefGoogle Scholar
  3. 3.
    Meinertz T, Nawrath H, Scholz H (1976) Possible role of cyclic AMP in the relaxation process of mammalian heart: Effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles. Naunyn Schmiedeberg’s Arch Pharmacol 293: 129–137Google Scholar
  4. 4.
    Petersen R, Hasch H, Heinz N (1977) Darstellung und Eigenschaften einiger Glukuronide und Sulfate von Cardenoliden und Cardenolid-glykosiden. Arzneim-Forsch. ( Drug Res ) 27: 642–649Google Scholar
  5. 5.
    Rietbrock N, Woodcock RG (1981) Pharmacokinetics of digoxin and derivatives. In: Handbook of Experimental Pharmacology, Vol 56/11, Cardiac glycosides, Part II, Pharmacokinetics and clinical pharmacology ( K. Greeff, ed), pp 31–56. ( Springer, Berlin Heidelberg New York )Google Scholar
  6. 6.
    Storstein L (1981) Pharmacokinetics of digitoxin. In: Handbook of Experimental Pharmacology, Vol 56/11, Cardiac glycosides, Part II, Pharmacokinetics and clinical pharmacology ( K. Greeff, ed), pp 3–30. Springer, Berlin, Heidelberg, New YorkGoogle Scholar
  7. 7.
    Storstein L, Scholz H, Oelert H, Flasch H, Schmitz W, Larsen A Clinical importance of conjugated digitoxin and digoxin metabolites in man. Submitted for publication 1983Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1984

Authors and Affiliations

  • Hasso Scholz
    • 1
  • W. Schmitz
    • 1
  1. 1.Abteilung Allgemeine PharmakologieUniversitäts-Krankenhaus EppendorfHamburg 20Germany

Personalised recommendations